The earnings call presented a generally positive outlook with consistent growth in key segments like Salix and Solta, successful debt refinancing, and strategic acquisitions. However, challenges remain in specific regions like China and LATAM, and there are concerns about future pricing impacts due to the IRA on Xifaxan.

Company Guidance -

Q3 2025

During Bausch Health's second quarter of 2025 earnings call, the company reaffirmed its full-year guidance, projecting revenues between $4.95 billion and $5.1 billion, with a midpoint representing a 4% increase year-over-year. The guidance for adjusted EBITDA remains between $2.625 billion and $2.725 billion, with an anticipated 5% increase from 2024. The company also expects adjusted operating cash flow to be between $825 million and $875 million. Bausch Health, excluding Bausch + Lomb, reported a 5% revenue growth to $1.252 billion and a 10% increase in adjusted EBITDA to $676 million. The call highlighted continued strong performance in the Salix segment, with 12% growth driven by Xifaxan's 10% increase, and substantial growth in the Solta segment, which saw a 25% revenue jump. Despite macroeconomic challenges impacting LATAM, double-digit growth was achieved in Canada and EMEA.

Consistent Revenue and EBITDA Growth

Bausch Health delivered its ninth consecutive quarter of revenue and adjusted EBITDA growth, with a 5% year-over-year revenue increase and a 10% increase in adjusted EBITDA.

Strong Performance in Salix and Solta Segments

Salix segment profit increased by 21% with a 12% growth in revenue driven by Xifaxan's 10% growth. Solta segment achieved a 25% increase in revenue, with 115% organic growth in South Korea.

Successful Debt Refinancing

Completed a $7.9 billion debt refinancing, extending maturities and reducing high-interest debt to improve the capital structure.

Strategic Acquisition Announcement

Announced an agreement to acquire DURECT Corporation to develop a treatment for alcohol hepatitis, demonstrating commitment to advancing R&D and business development.

Solid International Growth

EMEA achieved its 10th consecutive quarter of organic growth with a 6% increase. Canada also showed strong performance with successful product launches.

Bausch Health Companies (BHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BHC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	1.11 / -	1.153	―	―	―
Jul 30, 2025	2025 (Q2)	0.92 / 1.05	1.068	-1.90% (-0.02)
Apr 30, 2025	2025 (Q1)	0.84 / 0.61	0.625	-2.67% (-0.02)
Feb 19, 2025	2024 (Q4)	1.17 / 1.17	0.95	23.65% (+0.22)
Oct 30, 2024	2024 (Q3)	1.03 / 1.15	1.072	7.57% (+0.08)
Jul 31, 2024	2024 (Q2)	0.87 / 1.07	0.792	34.83% (+0.28)
May 02, 2024	2024 (Q1)	0.68 / 0.63	0.541	15.53% (+0.08)
Feb 22, 2024	2023 (Q4)	1.00 / 0.95	1.028	-7.61% (-0.08)
Nov 02, 2023	2023 (Q3)	0.91 / 1.07	0.787	36.28% (+0.29)
Aug 03, 2023	2023 (Q2)	0.68 / 0.79	0.517	53.22% (+0.28)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BHC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$6.39	$5.89	-7.82%
Apr 30, 2025	$5.30	$5.30	0.00%
Feb 19, 2025	$6.51	$7.18	+10.29%
Oct 30, 2024	$8.17	$9.20	+12.61%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bausch Health Companies (BHC) report earnings?

Bausch Health Companies (BHC) is schdueled to report earning on Oct 30, 2025, Before Open (Confirmed).

What is Bausch Health Companies (BHC) earnings time?

Bausch Health Companies (BHC) earnings time is at Oct 30, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BHC EPS forecast?

BHC EPS forecast for the fiscal quarter 2025 (Q3) is 1.11.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing